Patients carrying the FTO rs9939609 A-allele variantassociated with higher baseline appetite driveoften respond more dramatically to tirzepatide's dual signaling
That said, the goal isn't to keep you on medication forever your provider will talk with you about duration, tapering, and what an exit looks like
10.1186/s13018-023-03656-1 [DOI] [PMC free article] [PubMed] [Google Scholar] Liu H., Xiao H., Lin S., Zhou H., Cheng Y., Xie B., et al
Our findings underscore the possibility for wider applications for these medications but also highlight important risks that should be carefully monitored in people taking these drugs. Nature Medicine: Mapping the effectiveness and risks of GLP-1 receptor agonists
These formulations are prepared by FDA-registered, inspected compounding pharmacies
Long-Term Use of Semaglutide Whats the Difference